TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770–5p axis in PDAC
Wenjie Huang, Xiaojun Hu, Xiang He, Dongyue Pan, Zhaorong Huang, Zhanfeng Gu, Guobing Huang, Ping Wang, Chunhui Cui, Yingfang Fan
Topics & Concepts
MAPK/ERK pathwayIn vivoGemcitabineCancer researchIn vitroDownregulation and upregulationBiologySignal transductionCell biologyChemotherapyGeneticsGeneinterferon and immune responsesPancreatic and Hepatic Oncology ResearchChromatin Remodeling and Cancer